Abstract The mutation of TP53 gene affects half of all human cancers, resulting in impairment of the regulation of several cellular functions, including cell cycle progression and cell death in response to genotoxic stress. In the recent years additional p53-mediated tumour suppression mechanisms have been described, questioning the contribution of its canonical pathway for tumour suppression. These include regulation of alternative cell death modalities (i.e. ferroptosis), cell metabolism and the emerging role in RNA stability. Here we briefly summarize our knowledge on p53 “canonical DNA damage response” and discuss the most relevant recent findings describing potential mechanistic explanation of p53-mediated tumour suppression
The tumor protein TP53 gene, encoding the cellular tumor antigen p53, is the single most frequently ...
The p53 tumour suppressor is best known for its canonical role as “guardian of the genome”, activati...
Loss of p53 function occurs during the development of most, if not all, tumour types. This paves the...
The mutation of TP53 gene affects half of all human cancers, resulting in impairment of the regulati...
The mutation of TP53 gene affects half of all human cancers, resulting in impairment of the regulati...
The mutation of TP53 gene affects half of all human cancers, resulting in impairment of the regulati...
The mutation of TP53 gene affects half of all human cancers, resulting in impairment of the regulati...
The mutation of TP53 gene affects half of all human cancers, resulting in impairment of the regulati...
The TP53 tumor suppressor is the most frequently mutated gene in human cancer. p53 suppresses tumori...
The TP53 tumor suppressor is the most frequently mutated gene in human cancer. p53 suppresses tumori...
The tumour suppressor p53 regulates different cellular pathways involved in cell survival, DNA repai...
DNA damage triggers a checkpoint response that involves a myriad of cellular responses including cel...
DNA damage triggers a checkpoint response that involves a myriad of cellular responses including cel...
The tumor protein TP53 gene, encoding the cellular tumor antigen p53, is the single most frequently ...
Activation of the tumour suppressor p53 upon cellular stress can induce a number of different cellul...
The tumor protein TP53 gene, encoding the cellular tumor antigen p53, is the single most frequently ...
The p53 tumour suppressor is best known for its canonical role as “guardian of the genome”, activati...
Loss of p53 function occurs during the development of most, if not all, tumour types. This paves the...
The mutation of TP53 gene affects half of all human cancers, resulting in impairment of the regulati...
The mutation of TP53 gene affects half of all human cancers, resulting in impairment of the regulati...
The mutation of TP53 gene affects half of all human cancers, resulting in impairment of the regulati...
The mutation of TP53 gene affects half of all human cancers, resulting in impairment of the regulati...
The mutation of TP53 gene affects half of all human cancers, resulting in impairment of the regulati...
The TP53 tumor suppressor is the most frequently mutated gene in human cancer. p53 suppresses tumori...
The TP53 tumor suppressor is the most frequently mutated gene in human cancer. p53 suppresses tumori...
The tumour suppressor p53 regulates different cellular pathways involved in cell survival, DNA repai...
DNA damage triggers a checkpoint response that involves a myriad of cellular responses including cel...
DNA damage triggers a checkpoint response that involves a myriad of cellular responses including cel...
The tumor protein TP53 gene, encoding the cellular tumor antigen p53, is the single most frequently ...
Activation of the tumour suppressor p53 upon cellular stress can induce a number of different cellul...
The tumor protein TP53 gene, encoding the cellular tumor antigen p53, is the single most frequently ...
The p53 tumour suppressor is best known for its canonical role as “guardian of the genome”, activati...
Loss of p53 function occurs during the development of most, if not all, tumour types. This paves the...